Dr Agarwal Healthcare IPO GMP Today

Dr Agrawal’s healthcare limited is all set to launch its IPO on January 29th 2025, with price band of 382-402 per share The ipo includes a fresh issue of 300 crore and offer for sale to offload up to 6.78 crore crore shares, making the total issue size around 3027 crore at upper price band. As of now, Dr Agarwal healthcare IPO GMP Today is 10, indicating decrease in gmp from its peak of 160, expected listing price will be 412.

Dr. Agarwal’s healthcare limited is a leading eye care chain in India with a strong presence across the country. The IPO aims to raise funds from debt repayment business expansion and gender corporate purposes. Which are interesting in the free market the two is one of the most awaited offering in their healthcare sector.

Dr Agarwal Healthcare IPO GMP Today

The Dr. Agarwal’s Healthcare IPO GMP Today stands at 12 as of January 29th 2025. this premium suggests investor are optimistic about the company’s market debut and indicates strong listing gains. however, GMP is decreased from its peak and it is subject to change.

Dr Agarwal Healthcare IPO Details

Details	Information
Issue Size	₹3,027 crore
Fresh Issue	₹300 crore
Offer for Sale (OFS)	Up to 6.78 crore equity shares (₹2,727 crore)
Price Band	₹382 to ₹402 per share
Market Lot (Lot Size)	35 shares
Minimum Investment	₹14,070
IPO Opening Date	January 29, 2025
IPO Closing Date	January 31, 2025
Basis of Allotment Date	February 4, 2025
Refunds Initiation Date	February 5, 2025
Demat Credit Date	February 6, 2025
Listing Date	February 7, 2025

Dr. Agarwal’s Healthcare IPO Objectives

The money raised from the ipo will be used for:

Repaying or preparing loans to improve the company Financial health.
expanding operations by setting up new centers.
General corporate purposes.

Dr Agarwal Healthcare Shareholder Quota

Dr Agrawal’s healthcare IPO has a special shareholder’s quota reserved for those who already own share of its parent company Dr Agrawals eye hospital. To be eligible you must have shares of Dr Agarwal’s eye hospital as of January 22 2025.

Under this quota about 1.5% of the total IPO size is reserved Eligible shareholders can apply for shares worth up to 2,00,000 This affliction is separate from the retail investor category Meaning you can apply under both categories If you meet the criteria.’s way for the company To reward its existing shareholders giving them a chance to benefit from the IPO directly.

About Dr Agarwal’s Healthcare

Dr. Agrawal’s health care is one of Indias top ik service provided The company offers comprehensive I care solutions including Cataract, surgeries Refractive surgeries, consultations diagnostic services and optical products. With 193 facilities across 117 cities, the company has served over 2.13 million patients And performed 220,5223 Surgeries as of September 2024.

Company product and services

Cataract surgeries
Refractive surgeries
Comprehensive eye consultations
Diagnostic services
Non surgical treatments
Optical products
Contact lens
Eye care pharmaceuticals

Official Website : https://www.dragarwal.com/

Financial Performance

Period Ended	Revenue	Expense	Profit After Tax	Assets
2022	₹713	₹657	₹43	₹1,026
2023	₹1,031	₹947	₹103	₹1,825
2024	₹1,376	₹1,235	₹95	₹2,752
September 2024	₹837	₹777	₹39	₹3,393

Dr Agarwal’s financial performance reflects a growing and stable business. the revenue show growth shows strong market demand, While manageable debt levels and consistent profitability indicates sound financial management. however, the relatively moderate pat suggest that the company has room to improve margins by optimizing costs or enhancing operational efficiency. Investors might view this as a stable company with growth potential particularly in the expanding healthcare sector but they should weigh it against other investment opportunities with higher profitability Metrics.

Promoter Holdings

the promoters of Dr Agrawal’s healthcare include when non investment firms like Arvond investment Pvt.ltd And claymore investments, Who will partially offload their holdings through the OFS.

Dr Agarwal Healthcare IPO Good Or Bad

Dr Agrawal’s healthcare IPO has both positive and cautious aspects. The company is leading name in I care with strong market presence and steady revenue growth. Its extension network of centers and the growing demand for healthcare services in India may be an attractive opportunity. The grey market premium of ₹10 indicates neutral interest suggesting nominal potential for listing gains.

However, there are some concerns. the companies profit margins are modest and the valuation at 404 per share apearing high compared to its earnings. Additionally, The healthcare sector is competitive which could impact long term growth. For short term mistakes in the IPO may offer solid listing gains due to high GMP But long term investors its worth considering Companies stable growth but moderate property ability before making a decision.

Disclaimer – Information shared here is only for educational Purpose and do not take as financial advice. Before taking any investment decision please consult with your financial advisor.

Pravin Bhosale

Since stepping into the world of trading in 2019, i have gained valuable experience navigating the markets, have knowldge in indices like Bank Nifty, Nifty IT, Sensex, Bankex, and Finifty. Also have sound knowldge about IPO industry & ipo process. our blog aims to make finance approachable, offering practical insights for readers to better understand and act on market trends.